Concepedia

Author

Jodie Crawford

University of Manchester

Also Known As

J Crawford, J. Crawford, Jodie Crawford

32

Publications

374

Citations

7

H-Index

16

Concepts

All Affiliations

University of ManchesterSalford Royal NHS Foundation TrustManchester Academic Health Science CentreChina-Japan Friendship HospitalGlaxoSmithKline (United Kingdom)
JC

About

Jodie Crawford is an author at University of Manchester specializing in clinical trials, medicine, and asthma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

59

2

Public Health

1

1

38

3

Allergy

1

1

21

4

Allergy Medicine

1

1

21

5

Epidemiology

1

1

38

Jodie Crawford

×

7

Publications

357

Citations

7

H-Index

YearCitations

Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice

Jørgen Vestbo, David Leather, Nawar Diar Bakerly,

New England Journal of Medicine

2016

191

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β<sub>2</sub>agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial

Paul M. O’Byrne, Eugene R. Bleecker, Jan Lötvall,

Thorax

2013

74

Effectiveness <i>versus</i> efficacy trials in COPD: how study design influences outcomes and applicability

Ashley Woodcock, I. Boucot, David Leather,

European Respiratory Journal

2018

38

Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: A randomized trial

Jiangtao Lin, Jian Kang, Sang Haak Lee,

Respiratory Medicine

2014

21

Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study

Yoichi Nakamura, Soichiro Hozawa, Hironori Sagara,

Current Medical Research and Opinion

2021

12

Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist

Jiangtao Lin, Huaping Tang, Ping Chen,

Allergy and Asthma Proceedings

2016

11

Is Asthma Clinical Remission Achievable by Inhaled Therapy? A Post-Hoc Analysis of Single Inhaler Triple Therapy with FF/UMEC/VI in the CAPTAIN Trial

Njira Lugogo, John Oppenheimer, Jodie Crawford,

Journal of Allergy and Clinical Immunology

2024

10

Page 1